About Us
Who We Are
What We Do
What We Offer
Drug Discovery
Biotherapeutic Development
Senior Scientists
Scientific Advisory Board
Case Studies
Pipeline
Strategic Alliances
Development Funding
Agents In Clinical Development
Institutes & Charities
Start-up Companies
Archive
Press Releases 2005
30 November 2005
PIramed Announce Collaboration with Genentech for the Development and Commercialisation of New Anti-Cancer Drugs Licensed to PIramed by Cancer Research Technology, The Ludwig Institute of Cancer Research and the Institute of Cancer Research
28 November 2005
Spear Thearapeutics Raise $8.5 million to fund Cancer Drug Development
8 November 2005
The Norwegian Radium Hospital Research Foundation and Cancer Research Technology form a strategic alliance
26 September 2005
CellCentric and Cancer Research Technology Initiate Co-Development Partnership
20 September 2005
MerLion Pharmaceuticals Pte Ltd and Cancer Research Technology Announce Drug Discovery Collaboration
22 August 2005
Cancer Research Technology Announces License to TriPath Imaging, Inc. of Novel Cancer Diagnostic Markers
1 August 2005
Phogen Enters into Technology Commercialisation Agreement with Cancer Research Technology
27 July 2005
AstraZeneca and Astex Announce Strategic Alliance Focused on Novel Inhibitors Discovered Under a Collaborative Programme Between Astex, The Institute of Cancer Research and Cancer Research Technology
25 July 2005
Sareum Holdings, The Institute of Cancer Research and Cancer Research Technology Announce Major Cancer Drug Discovery Collaboration
16 June 2005
Alnylam and CRT Report Grant of Fundamental RNAi Patent by the European Patent Office
10 May 2005
Cancer Research Technology announces the appointment of Dr Phil L'Huillier as Director of Business Management
9 May 2005
Viragen Licenses 'Anti-CD55 Antibody' Cancer Therapy from Cancer Research Technology
26 April 2005
Ikonisys Inc. Enters into a Research Collaboration and Option Agreement with Cancer Research Technology Covering Automated Microscopy and Rare Cell Diagnostics in Cancer
11 April 2005
Cancer Research Technology and Sareum announce extension of Research Collaboration
23 March 2005
Cancer Research Technology and Genvax Enter into Licence Agreement for the Development of Leukaemia Research Fund Flagship Vaccine Technology Generated at the University of Southampton
17 March 2005 Viragen Antibody Enhances Effect of Leading Cancer Drug
16 February 2005
The University of Cambridge, Cancer Research Technology, Cancer Research UK and Perlegen Sciences Collaborate to Analyse Thousands of DNA Samples from Breast Cancer Patients
10 January 2005 Xenova Licenses TA-CIN to Cancer Research Technology
